Genotype Distribution in HCV-Positive Patients With (MG) or Without (Controls) Monoclonal Gammopathy
| HCV Genotypes . | 1a . | 1b . | 2 (a/c) . | 3a . | 1a + 1b . |
|---|---|---|---|---|---|
| MG (18 pts) | 1 (5.5%) | 5 (28%) | 10 (55.5%) | 0 | 2 (11%) |
| P | NS | .02 | .009 | NS | NS |
| Controls (36 pts) | 4 (11%) | 22 (61%) | 7 (19%) | 2 (5.5%) | 1 (3%) |
| HCV Genotypes . | 1a . | 1b . | 2 (a/c) . | 3a . | 1a + 1b . |
|---|---|---|---|---|---|
| MG (18 pts) | 1 (5.5%) | 5 (28%) | 10 (55.5%) | 0 | 2 (11%) |
| P | NS | .02 | .009 | NS | NS |
| Controls (36 pts) | 4 (11%) | 22 (61%) | 7 (19%) | 2 (5.5%) | 1 (3%) |
Results evaluated by Fisher's exact test.
Abbreviation: NS, not significant.